521. Comparative In Vitro Activity of Meropenem/Vaborbactam and Meropenem Against a Collection of Real-World Clinical Isolates of Pseudomonas aeruginosa

BACKGROUND: Meropenem/vaborbactam (MV) is a carbapenem and boronic acid–based β-lactamase inhibitor combination product with potent in vitro activity against Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. As carbapenem resistance in Pseudomonas aeruginosa (PSA) is primarily driven...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Twisha S, Kaye, Keith S, Krishnan, Jay, Marshall, Vince, Mills, John, Albin, Owen, Young, Carol, Smith, Aaron, Lephart, Paul, M. Pogue, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810788/
http://dx.doi.org/10.1093/ofid/ofz360.590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810788/
http://dx.doi.org/10.1093/ofid/ofz360.590

Ejemplares similares